SEARCH

SEARCH BY CITATION

References

  • 1
    Schiff L, Schiff E. Diseases of the liver. 1st ed. Philadelphia , PA : J.B. Lippincott; 1993.
  • 2
    Harper AM, Rosendale JD. The UNOS OPTN waiting list and donor registry: 1988-1996. Clin Transpl. 1996; 10: 6990.
  • 3
    Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998; 338: 174151.
  • 4
    UNOS-Database, http://www.unos.org/data, March 2007.
  • 5
    Gerlach JC, Encke J, Hole O, Müller C, Ryan CJ, Neuhaus P. Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation. 1994; 58: 9848.
  • 6
    Raper SE. Hepatocyte transplantation and gene therapy. Clin Transplant. 1995; 9: 24954.
  • 7
    Asonuma K, Gilbert JC, Stein JE, Takeda T, Vacanti JP. Quantitation of transplanted hepatic mass necessary to cure the Gunn rat model of hyper-bilirubinemia. J Pediatr Surg. 1992; 27: 298301.
  • 8
    Anderson NG. The mass isolation of whole cells from rat liver. Science. 1953; 117: 6278.
  • 9
    Howard RB, Christensen AK, Gibbs FA, Pesch LA. The enzymatic preparation of isolated intact parenchymal cells from rat liver. J Cell Biol. 1967; 35: 67584.
  • 10
    Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol. 1969; 43: 50620.
  • 11
    Seglen PO, Jervell KF. A simple perfusion technique applied to glucocorticoid regulation of tryptophan oxygenase turnover and bile production in the isolated rat liver. Hoppe Seylers Z Physiol Chem. 1969; 350: 30816.
  • 12
    Liu XL, Li LJ, Chen Z. Isolation and primary culture of rat hepatocytes. Hepatobiliary Pancreat Dis Int. 2002; 1: 779.
  • 13
    Koenig S, Krause P, Drabent B, Schaeffner I, Christ B, Schwartz P, Unthan-Fechner K, Probst I. The expression of mesenchymal, neural and haematopoietic stem cell markers in adult hepatocytes proliferating in vitro. J Hepatol. 2006; 44: 111524.
  • 14
    Meredith MJ. Rat hepatocytes prepared without collagenase: prolonged retention of differentiated characteristics in culture. Cell Biol Toxicol. 1988; 4: 40525.
  • 15
    Wang SR, Renaud G, Infante J, Catala D, Infante R. Isolation of rat hepatocytes with EDTA and their metabolic functions in primary culture. in vitro Cell Dev Biol. 1985; 21: 52630.
  • 16
    Fiegel HC, Lange C, Kneser U, Lambrecht W, Zander AR, Rogiers X, Kluth D. Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med. 2006; 10: 57787.
  • 17
    Lange C, Bassler P, Lioznov MV, Bruns H, Kluth D, Zander AR, Fiegel HC. Liver-specific gene expression in mesenchymal stem cells is induced by liver cells. World J Gastroenterol. 2005; 11: 4497504.
  • 18
    Lange C, Bruns H, Kluth D, Zander AR, Fiegel HC. Hepatocytic differentiation of mesenchymal stem cells in cocultures with fetal liver cells. World J Gastroenterol. 2006; 12: 23947.
  • 19
    Ong SY, Dai H, Leong KW. Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials. 2006; 27: 408797.
  • 20
    Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M, Sato T, Miyanishi K, Takayama T, Takahashi M, Takimoto R, Iyama S, Matsunaga T, Ohtani S, Matsuura A, Hamada H, Niitsu Y. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood. 2005; 106: 75663.
  • 21
    Moviglia GA, Varela G, Gaeta CA, Brizuela JA, Bastos F, Saslavsky J. Autoreactive t cells induce in vitro BM mesenchymal stem cell transdifferentiation to neural stem cells. Cytotherapy. 2006; 8: 196201.
  • 22
    Kaufmann PM, Sano K, Uyama S, Takeda T, Vacanti JP. Heterotopic hepatocyte transplantation: assessing the impact of hepatotrophic stimulation. Transplant Proc. 1994; 26: 22401.
  • 23
    Mooney D, Hansen L, Vacanti J, Langer R, Farmer S, Ingber D. Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol. 1992; 151: 497505.
  • 24
    Berthiaume F, Moghe PV, Toner M, Yarmush ML. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration. FASEB J. 1996; 10: 147184.
  • 25
    Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, Riley T, Howard TA, Michalopoulos GK. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol. 1996; 132: 113349.
  • 26
    Reid LM. Stem cell biology, hormone/matrix synergies and liver differentiation. Curr Opin Cell Biol. 1990; 2: 12130.
  • 27
    Guguen-Guillouzo C, Clément B, Baffet G, Beaumont C, Morel-Chany E, Glaise D, Guillouzo A. Maintenance and reversibility of active albumin secretion by adult rat hepatocytes co-cultured with another liver epithelial cell type. Exp Cell Res. 1983; 143: 4754.
  • 28
    Shimaoka S, Nakamura T, Ichihara A. Stimulation of growth of primary cultured adult rat hepatocytes without growth factors by coculture with non-parenchymal liver cells. Exp Cell Res. 1987; 172: 22842.
  • 29
    Bhatia SN, Balis UJ, Yarmush ML, Toner M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J. 1999; 13: 1883900.
  • 30
    Mizuguchi T, Hui T, Palm K, Sugiyama N, Mitaka T, Demetriou AA, Rozga J. Enhanced proliferation and differentiation of rat hepatocytes cultured with bone marrow stromal cells. J Cell Physiol. 2001; 189: 10619.
  • 31
    Rozga J, Williams F, Ro MS, Neuzil DF, Giorgio TD, Backfisch G, Moscioni AD, Hakim R, Demetriou AA. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology. 1993; 17: 25865.
  • 32
    Kaufmann PM, Heimrath S, Kim BS, Mooney DJ. Highly porous polymer matrices as a three-dimensional culture system for hepatocytes. Cell Transplant. 1997; 6: 4638.
  • 33
    Török E, Pollok JM, Ma PX, Vogel C, Dandri M, Petersen J, Burda MR, Kaufmann PM, Kluth D, Rogiers X. Hepatic tissue engineering on 3-dimensional biodegradable polymers within a pulsatile flow bioreactor. Dig Surg. 2001; 18: 196203.
  • 34
    Pearse MJ, Witort E, Mottram P, Han W, Murray-Segal L, Romanella M, Salvaris E, Shinkel TA, Goodman DJ, D'Apice AJ. Antigal antibody-mediated allograft rejection in alpha1, 3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection. Transplantation. 1998; 66: 74854.
  • 35
    Obermayer N, Busse B, Grünwald A, Mönch E, Müller C, Neuhaus P, Gerlach JC. Biochemical characterization of bioreactors for hybrid liver support: serum-free liver cell coculture of nonparenchymal and parenchymal cells. Transplant Proc. 2001; 33: 19301.
  • 36
    Bartolo LD, Bader A. Flat membrane bioreactor for the replacement of liver functions. Ernst Schering Res Found Workshop. 2002; 35: 89104.
  • 37
    Fiegel HC, Bruns H, Höper C, Lioznov MV, Kluth D. Cell growth and differentiation of different hepatic cells isolated from fetal rat liver in vitro. Tissue Eng. 2006; 12: 12330.
  • 38
    Yanagi K, Ookawa K, Mizuno S, Ohshima N. Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel. ASAIO Trans. 1989; 35: 5702.
  • 39
    Doré E, Legallais C. A new concept of bioartificial liver based on a fluidized bed bioreactor. Ther Apher. 1999; 3: 2647.
  • 40
    O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 1988; 94: 118692.
  • 41
    Stange J, Mitzner S, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein bound drugs and toxins. ASAIO J. 1993; 39: M6215.
  • 42
    Sorrentino F. Prime ricerche per la realizzatione di un fegato artificiale. Chir Patol Sper. 1956; 4: 1401.
  • 43
    Wolf CF, Munkelt BE. Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. Trans Am Soc Artif Intern Organs. 1975; 21: 1627.
  • 44
    Nyberg SL, Remmel RP, Mann HJ, Peshwa MV, Hu WS, Cerra WF. Primary hepatocytes outperform Hep-G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg. 1994; 220: 5967.
  • 45
    Sussman NL, Gislason GT, Conlin CA, Kelly JH. The hepatic extracorporeal liver assist device: initial clinical experience. Artif Organs. 1994; 18: 3906.
  • 46
    Millis MJ, Cronin DC, Johnson R, Conjeevaram H, Conlin C, Trevino S, Maguire P. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation. 2002; 74: 173546.
  • 47
    Demetriou AA, Brown RS, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Esch JSA, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, De Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, Mata MDL, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004; 239: 6607.
  • 48
    Stadlbauer V, Jalan R. Acute liver failure: liver support therapies. Curr Opin Crit Care. 2007; 13: 21521.
  • 49
    Sauer IM, Zeilinger K, Obermayer N, Pless G, Grünwald A, Pascher A, Mieder T, Roth S, Goetz M, Kardassis D, Mas A, Neuhaus P, Gerlach JC. Primary human liver cells as source for modular extracorporeal liver support – a preliminary report. Int J Artif Organs. 2002; 25: 10015.
  • 50
    Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, Irgang M, Kraemer M, Puhl G, Frank J, Müller AR, Steinmüller T, Denner J, Neuhaus P, Gerlach JC. Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells. Xenotransplantation. 2003; 10: 4609.
  • 51
    Mundt A, Puhl G, Müller A, Sauer I, Müller C, Richard R, Fotopoulou C, Doll R, Gäbelein G, Höhn W, Hofbauer R, Neuhaus P, Gerlach J. A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver support. Int J Artif Organs. 2002; 25: 5428.
  • 52
    Flendrig LM, La Soe JW, Jörning GG, Steenbeek A, Karlsen OT, Bovée WT, Ladiges NC, Te Velde AA, Chamuleau RA. In vitro evaluation of a novel biore-actor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol. 1997; 26: 137992.
  • 53
    Van de Kerkhove MP, Florio ED, Scuderi V, Mancini A, Belli A, Bracco A, Dauri M, Tisone G, Nicuolo GD, Amoroso P, Spadari A, Lombardi G, Hoekstra R, Calise F, Chamuleau RA. Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs. 2002; 25: 9509.
  • 54
    Patzer JF, Mazariegos GV, Lopez R, for the RAP Investigators. Preclinical evaluation of the Excorp Medical, Inc, bioartificial liver support system. J Am Coll Surg. 2002; 195: 299310.
  • 55
    Mito M, Ebata H, Kusano M, Onishi T, Saito T, Sakamoto S. Morphology and function of isolated hepatocytes transplanted into rat spleen. Transplantation. 1979; 28: 499505.
  • 56
    Xiangdong W, Ar'Rajab A, Ahrén B, Andersson R, Bengmark S. The effect of pancreatic islets on transplanted hepatocytes in the treatment of acute liver failure in rats. Res Exp Med. 1991; 191: 42935.
  • 57
    Demetriou AA, Whiting JF, Feldman D, Levenson SM, Chowdhury NR, Moscioni AD, Kram M, Chowdhury RJ. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science. 1986; 233: 11902.
  • 58
    Holzman MD, Rozga J, Neuzil DF, Griffin D, Moscioni AD, Demetriou AA. Selective intraportal hepatocyte transplantation in analbuminemic and Gunn rats. Transplantation. 1993; 55: 12139.
  • 59
    Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, Dorko K, Sauter BV, Strom SC. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998; 338: 14226.
  • 60
    Nieto JA, Escandón J, Betancor C, Ramos J, Cantón T, Cuervas-Mons V. Evidence that temporary complete occlusion of splenic vessels prevents massive embolization and sudden death associated with intrasplenic hepatocellular transplantation. Transplantation. 1989; 47: 44950.
  • 61
    Benedetti E, Kirby JP, Asolati M, Blanchard J, Ward MG, Williams R, Hewett TA, Fontaine M, Pollak R. Intrasplenic hepatocyte allotransplantation in dalmatian dogs with and without cyclosporine immunosuppression. Transplantation. 1997; 63: 12069.
  • 62
    Inber DE. Extracellular matrix and the development of tissue architecture: a mechanochemical perspective. In: ZernMA, ReidLM, editors. Extracellular matrix. New York : Marcel Dekker, Inc.; 1993. pp. 40328.
  • 63
    Langer R, Vacanti JP. Tissue engineering. Science. 1993; 260: 9206.
  • 64
    Uyama S, Kaufmann PM, Kneser U, Fiegel HC, Pollok JM, Kluth D, Vacanti JP, Rogiers X. Hepatocyte transplantation using biodegradable matrices in ascorbic acid-deficient rats: comparison with heterotopically transplanted liver grafts. Transplantation. 2001; 71: 122631.
  • 65
    Hkrach JS, Ou J, Lothan N, Langer R. Poly(l-lactic acid-co-aspartic acid): interactive polymers for tissue engineering. Polymers in medicine and pharmacy. Symposium Proceedings 394, A.G. In: MikosKW, LeongMJ, YaszemskiJA, TamadaML, RadomskyKW, editors. Pittsburgh , PA : Materials Research Society; 1995: pp. 7782.
  • 66
    Bleiziffer O, Eriksson E, Yao F, Horch RE, Kneser U. Gene transfer strategies in tissue engineering. J Cell Mol Med. 2007; 11: 20623.
  • 67
    Gilbert JC, Takada T, Stein JE, Langer R, Vacanti JP. Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats. Transplantation. 1993; 56: 4237.
  • 68
    Kaufmann PM, Kneser U, Fiegel HC, Kluth D, Herbst H, Rogiers X. Long-term hepatocyte transplantation using three-dimensional matrices. Transplant Proc. 1999; 31: 19289.
  • 69
    Johnson LB, Aiken J, Mooney D, Schloo BL, Griffith-Cima L, Langer R, Vacanti JP. The mesentery as a laminated vascular bed for hepatocyte transplantation. Cell Transplant. 1994; 3: 27381.
  • 70
    Mooney DJ, Sano K, Kaufmann PM, Majahod K, Schloo B, Vacanti JP, Langer R. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res. 1997; 37: 41320.
  • 71
    Harley HA, Morgan T, Redeker AG, Reynolds TB, Villamil F, Weiner JF, Yellin A. Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology. 1986; 91: 8029.
  • 72
    Starzl TE, Francavilla A, Halgrimson CG, Francavilla FR, Porter KA, Brown TH, Putnam CW. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet. 1973; 137: 17999.
  • 73
    Kaufmann PM, Kneser U, Fiegel HC, Pollok JM, Kluth D, Izbicki JR, Herbst H, Rogiers X. Is there an optimal concentration of cotransplanted islets of Langerhans for stimulation of hepatocytes in three dimensional matrices? Transplantation. 1999; 68: 2729.
  • 74
    Kneser U, Kaufmann PM, Fiegel HC, Pollok JM, Rogiers X, Kluth D, Herbst H. Interaction of hepatocytes and pancreatic islets cotransplanted in polymeric matrices. Virchows Arch. 1999; 435: 12532.
  • 75
    Kneser U, Polykandriotis E, Ohnolz J, Heidner K, Grabinger L, Euler S, Amann KU, Hess A, Brune K, Greil P, Stürzl M, Horch RE. Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng. 2006; 12: 172131.
  • 76
    Polykandriotis E, Arkudas A, Horch RE, Stürzl M, Kneser U. Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical science. J Cell Mol Med. 2007; 11: 620.
  • 77
    Bach AD, Arkudas A, Tjiawi J, Polykandriotis E, Kneser U, Horch RE, Beier JP. A new approach to tissue engineering of vascularized skeletal muscle. J Cell Mol Med. 2006; 10: 71626.
  • 78
    Kneser U, Stangenberg L, Ohnolz J, Buettner O, Stern-Straeter J, Möbest D, Horch RE, Stark GB, Schaefer DJ. Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model. J Cell Mol Med. 2006; 10: 695707.
  • 79
    Horch RE. Future perspectives in tissue engineering. J Cell Mol Med. 2006; 10: 719.
  • 80
    Fidkowski C, Kaazempur-Mofrad MR, Borenstein J, Vacanti JR, Langer R, Wang Y. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng. 2005; 11: 3029.
  • 81
    Shin M, Matsuda K, Ishii O, Terai H, Kaazempur-Mofrad MR, Borenstein J, Vacanti JP. Endothelialized networks with a vascular geometry in microfabricated poly (dimethyl siloxane). Biomed Microdevices. 2004; 6: 26978.
  • 82
    Mazariegos GV, Kramer DJ, Lopez RC, Obaid Shakil A, Rosenbloom AJ, DeVera M, Giraldo M, Grogan TA, Zhu Y, Fulmer ML, Amiot BP, Patzer JF. Safety observations in phase I clinical evaluation of the Excorp medical bioartificial liver support system after the first four patients. ASAIO J. 2001; 47: 4715.